Pierre Gourdy to Dipeptidyl-Peptidase IV Inhibitors
This is a "connection" page, showing publications Pierre Gourdy has written about Dipeptidyl-Peptidase IV Inhibitors.
Connection Strength
0.149
-
Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study. Diabetes Obes Metab. 2021 05; 23(5):1162-1172.
Score: 0.149